Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome
Clinical trial NCT02713945 · COMPLETED
Trial details
- NCT number
- NCT02713945
- Sponsor
- University Hospital, Toulouse
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-25
- Primary completion
- 2023-03-03
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.